Abstract
Purpose
There is a real need to adapt simple and reproducible imaging methodologies to evaluate noninvasively pro- and antiangiogenic activities of new treatments in a physiological context in mice.
Procedure
The angiogenic response to fibroblast growth factor 2 (FGF-2) in a model of subcutaneously implanted cellulose sponges was measured in parallel after an intravenous injection of a fluorescent αvβ3 integrin-targeting molecule (AngioloneTM) and an fluorescence diffuse optical tomography optical imaging system and by measuring the hemoglobin content in the sponges.
Results
Optical measurements of angiogenesis correlated perfectly with the values obtained using hemoglobin quantification. This assay can be used to follow the activity of a pro- or antiangiogenic treatment like demonstrated after FGF-2 or angiostatin, respectively.
Conclusion
The perfectly controlled quality of cellulose sponges combined to this noninvasive optical method allow rapid, accurate, and reproducible measurements of angiogenic activities in vivo at the preclinical level.
This is a preview of subscription content, log in via an institution to check access.
References
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186
Ferrara N, Hillan KJ, Gerber HP et al (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391–400
Pircher A, Hilbe W, Heidegger I et al (2011) Biomarkers in tumor angiogenesis and anti-angiogenic therapy. Int J Mol Sci 12:7077–7099
Vailhe B, Vittet D, Feige JJ (2001) In vitro models of vasculogenesis and angiogenesis. Lab Investig J Tech Methods Pathol 81:439–452
Beaumont M, Lemasson B, Farion R et al (2009) Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 29:1714–1726
Beaumont M, Odame I, Babyn PS et al (2009) Accurate liver T2 measurement of iron overload: a simulations investigation and in vivo study. J Magn Reson Imaging 30:313–320
Fukumura D, Jain RK (2008) Imaging angiogenesis and the microenvironment. APMIS 116:695–715
Vakoc BJ, Lanning RM, Tyrrell JA et al (2009) Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med 15:1219–1223
Jin ZH, Josserand V, Foillard S et al (2007) In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol Cancer 6:41
Stromblad S, Cheresh DA (1996) Integrins, angiogenesis and vascular cell survival. Chem Biol 3:881–885
Aumailley M, Gurrath M, Muller G et al (1991) Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett 291:50–54
Boturyn D, Coll JL, Garanger E et al (2004) Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. J Am Chem Soc 126:5730–5739
Jin ZH, Furukawa T, Galibert M et al (2011) Noninvasive visualization and quantification of tumor alphaVbeta3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4. Nucl Med Biol 38:529–540
Koenig A, Herve L, Da Silva A et al (2007) Whole body small animal examination with a diffuse optical tomography instrument. Nucl Inst Methods Phys Res A 571:56–59
Koenig A, Herve L, Gonon G et al (2010) Fluorescence diffuse optical tomography for free-space and multifluorophore studies. J Biomed Opt 15:016016
Koenig A, Herve L, Josserand V et al (2008) In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography. J Biomed Opt 13:011008
David L, Mallet C, Keramidas M et al (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102:914–922
Herve L, Koenig A, Da Silva A et al (2007) Noncontact fluorescence diffuse optical tomography off heterogeneous media. Appl Opt 46:4896–4906
Sancey L, Garanger E, Foillard S et al (2009) Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. Mol Ther 17:837–843
Napoli C, Giordano A, Casamassimi A et al (2011) Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer. Int J Cancer 128:1505–1508
Guedez L, Rivera AM, Salloum R et al (2003) Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am J Pathol 162:1431–1439
McCarty MF, Baker CH, Bucana CD et al (2002) Quantitative and qualitative in vivo angiogenesis assay. Int J Oncol 21:5–10
Robertson NE, Discafani CM, Downs EC et al (1991) A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis. Cancer Res 51:1339–1344
Malinda KM (2009) In vivo matrigel migration and angiogenesis assay. Methods Mol Biol 467:287–294
Garofalakis A, Dubois A, Kuhnast B et al (2010) In vivo validation of free-space fluorescence tomography using nuclear imaging. Opt Lett 35:3024–3026
Acknowledgments
This work was supported by Cancéropole CLARA, the Institut National du Cancer (INCA) and the French National Research Agency (ANR).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 595 kb)
Rights and permissions
About this article
Cite this article
Keramidas, M., Josserand, V., Feige, JJ. et al. Noninvasive and Quantitative Assessment of In Vivo Angiogenesis Using RGD-Based Fluorescence Imaging of Subcutaneous Sponges. Mol Imaging Biol 15, 239–244 (2013). https://doi.org/10.1007/s11307-012-0595-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-012-0595-6